Skip to content

A retrospective study on alopecia areata

A retrospective study on alopecia areata

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116383
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-10
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia areata

Interventions

Pediatric group (age 18 years).:

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with alopecia areata at Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine between October 2015 and October 2025, regardless of age and sex.

Exclusion criteria

Exclusion criteria: 1.Patients who have received treatments that may affect hair loss (such as chemotherapy or radiotherapy) within the past 3 months. 2.Patients with severe cardiac, hepatic, or renal insufficiency, or malignant tumors.

Design outcomes

Primary

MeasureTime frame
The abnormality rate of specific blood tests (e.g., autoantibodies, thyroid antibodies).;The proportions of concomitant diseases (e.g., autoimmune diseases, allergic diseases, thyroid disorders) and the positive rate of relevant family history.;Disease severity;

Countries

China

Contacts

Public ContactRuhong Cheng

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

shirleywo6@163.com+86 21 2507 8575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026